SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ocumetics Technology Corp. (OTC) Expects Group Two Lens Results by Year-End

Ocumetics says clinical, regulatory and manufacturing requirements for Group Two first-in-human lens implantations are complete and surgeries are imminent. Initial patient results are expected by year-end; potential negotiations could advance if results meet or exceed objectives.Material DetailsCon…

OTC

Related stories